Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone
- Conditions
- Pancreatic Stone Disease
- Interventions
- Registration Number
- NCT01998217
- Lead Sponsor
- Changhai Hospital
- Brief Summary
Extracorporeal shock wave lithotripsy (ESWL) of pancreatic stones has been described as an effective approach for stone drainage and pain relief, and general or epidural anesthesia has been reported for such procedure. Single infusion of remifentanil has been described in ESWL of urinary stones, but it has never been described in ESWL of pancreatic stones. Moreover, single infusion of remifentanil might induce several complications, such as postoperative nausea and vomiting. The investigators attended to investigated whether combination of flurbiprofen with remifentanil reduced remifentanil dose and attenuated the complications.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- aged 18-65 years
- ASA I-II
- ESWL indication was met
- patients with hypertension
- patients compromised in cardiopulmonary function
- patients undergoing ESWL for the second or more times
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Flur group Flurbiprofen and remifentanil Patients in this group receive both infusion of flurbiprofen and remifentanil Rem group Remifentanil Patients in this group receive single infusion of remifentanil with target concentration infusion.
- Primary Outcome Measures
Name Time Method Visual analogue score of pain During ESWL procedure
- Secondary Outcome Measures
Name Time Method Cardiovascular responses including blood pressure and heart rate During ESWL procedure
Trial Locations
- Locations (1)
Department of Anesthesiology, Changhai Hospital
🇨🇳Shanghai, Shanghai, China